Sign In
Buy AKBA
$0.97
+0.0333 (+3.56%)
At Close: Jun 03, 2026
Akebia Therapeutics (NASDAQ:AKBA) Stock Rating Lowered by BidaskClub
03:34am, Monday, 15'th Jun 2020
Akebia Therapeutics (NASDAQ:AKBA) was downgraded by investment analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Saturday, BidAskClub reports. Several other r
Akebia Therapeutics (NASDAQ:AKBA) Shares Up 6.3%
03:44am, Sunday, 14'th Jun 2020
Akebia Therapeutics Inc (NASDAQ:AKBA)’s share price shot up 6.3% during trading on Friday . The stock traded as high as $11.20 and last traded at $11.19, 1,402,030 shares were traded during trading.
Better Coronavirus Stock: OPKO Health or Emergent Biosolutions? | The Motley Fool
11:33am, Saturday, 13'th Jun 2020
Which stock wins in a battle between a COVID-19 testing leader and the top contract manufacturer for COVID-19 vaccines?
Akebia Therapeutics (AKBA) Upgraded to Buy: Here's What You Should Know
04:00pm, Friday, 12'th Jun 2020
Akebia Therapeutics (AKBA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
BMW releases new price list for all BMW, Mini and Motorrad models
11:28am, Friday, 12'th Jun 2020
BMW Group Malaysia has revised the prices of its BMW, Mini and BMW Motorrad products to exclude the sales tax on all completely knocked-down (CKD) models for the period of June 15 to Dec 31, 2020. Thi
Gubernur: Pangandaran contoh penerapan normal baru sektor pariwisata
08:50am, Thursday, 11'th Jun 2020
Gubernur Jawa Barat Ridwan Kamil (Kang Emil) mengapresiasi penerapan adaptasi kebiasaan baru (AKB) atau normal baru di objek wisata Pangandaran, sehingga bisa ...
Small Caps Build Steam And Biotechs Remain Well-Positioned
02:15pm, Wednesday, 10'th Jun 2020
Economic optimism has broadened the market rally. Small caps had lagged significantly and are now catching-up as they narrow the performance gap. The Federal Re
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that data from an investigational clini
Astellas Pharma : Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phase 3 DOLOMITES Study of Anemia | MarketScreener
02:34pm, Tuesday, 09'th Jun 2020FibroGen Announces New Roxadustat Data Presented at 2020 ERA-EDTA Virtual Congress | MarketScreener
09:01pm, Monday, 08'th Jun 2020
A new expert-led report has today been launched to help outline key challenges and inequalities in the care of type 2 diabetes mellitus (T2DM) and its
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:30pm, Tuesday, 02'nd Jun 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted three newly-hired employees options to purchase
Gubernur Jabar uraikan lima tahap adaptasi normal baru
12:57pm, Tuesday, 02'nd Jun 2020
Gubernur Jawa Barat (Jabar) yang juga Ketua Gugus Tugas Percepatan Penanggulangan COVID-19 Jabar M Ridwan Kamil mengemukakan lima tahap adaptasi normal ...
Chronic Kidney Disease (CKD) Epidemiology Forecast to 2030 - ResearchAndMarkets.com
12:00am, Tuesday, 02'nd Jun 2020
The
